Immunosuppressive therapy in patients with connective tissue disease‐associated pulmonary arterial hypertension: A systematic review
Y Ding, J Qian, S Zhang, D Xu, X Leng… - International Journal …, 2022 - Wiley Online Library
Objectives It is currently accepted that inflammation plays an important role in the
pathogenesis of connective tissue disease‐associated pulmonary arterial hypertension …
pathogenesis of connective tissue disease‐associated pulmonary arterial hypertension …
Additional use of prostacyclin analogs in patients with pulmonary arterial hypertension: a meta-analysis
P Wang, J Deng, Q Zhang, H Feng, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
Background: Combination therapy has become an attractive option in pulmonary arterial
hypertension (PAH) treatment. The aim of this study was to investigate whether additional …
hypertension (PAH) treatment. The aim of this study was to investigate whether additional …